4198
欣大健康
+0.10 (+0.20%)49.903成交張數–本益比5.90股價淨值比0.00%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入2025204年增 -15.0%
毛利率202532.9%最新一期
營業利益率2025-22.8%最新一期
每股盈餘2025-1.96
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 95.2% | 95.1% | 88.5% | 92.0% | 123.1% | 106.5% | 84.9% | 86.0% | 68.8% | 67.1% | |
| 營業毛利（毛損） | 4.8% | 4.9% | 11.5% | 8.0% | -23.1% | -6.5% | 15.1% | 14.0% | 31.2% | 32.9% | |
| 營業毛利（毛損）淨額 | 4.8% | 4.9% | 11.5% | 8.0% | -23.1% | -6.5% | 15.1% | 14.0% | 31.2% | 32.9% | |
| 推銷費用 | 35.7% | 36.9% | 28.5% | 23.6% | 16.9% | 13.7% | 17.9% | 17.0% | 25.3% | 22.2% | |
| 管理費用 | 49.8% | 38.1% | 44.1% | 37.5% | 55.6% | 44.8% | 26.9% | 26.9% | 30.3% | 29.5% | |
| 研究發展費用 | 30.1% | 18.5% | 12.9% | 19.0% | 35.7% | 19.9% | 8.4% | 5.9% | 4.2% | 4.4% | |
| 預期信用減損損失（利益） | – | – | -0.4% | -3.6% | 1.3% | -0.5% | 5.3% | 0.6% | -0.2% | -0.3% | |
| 營業費用合計 | 115.7% | 93.6% | 85.2% | 76.4% | 109.5% | 77.9% | 58.5% | 50.5% | 59.5% | 55.7% | |
| 營業利益（損失） | -110.8% | -88.7% | -73.7% | -68.4% | -132.6% | -84.4% | -43.4% | -36.5% | -28.3% | -22.8% | |
| 利息收入 | – | – | – | – | 0.3% | 0.1% | 0.0% | 0.2% | 0.5% | 0.5% | |
| 其他收入 | 2.6% | 1.2% | 3.6% | 2.9% | 22.4% | 9.6% | 13.5% | 6.7% | 1.4% | 1.0% | |
| 其他利益及損失淨額 | -7.5% | -1.6% | -3.1% | -17.1% | -1.4% | -1.8% | 3.2% | 72.1% | 8.0% | -0.3% | |
| 財務成本淨額 | 0.4% | 0.4% | 0.4% | 1.1% | 1.9% | 1.4% | 0.9% | 2.1% | 0.9% | 0.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | 1.1% | 0.0% | – | – | – | – | – | – | 0.0% | -1.7% | |
| 營業外收入及支出合計 | -4.2% | -0.8% | 0.2% | -15.4% | 19.3% | 6.5% | 15.8% | 76.9% | 9.0% | -0.9% | |
| 稅前淨利（淨損） | -115.0% | -89.5% | -73.6% | -83.8% | -113.3% | -78.0% | -27.7% | 40.4% | -19.3% | -23.7% | |
| 所得稅費用（利益）合計 | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | -0.5% | -0.0% | 0.9% | -0.2% | |
| 繼續營業單位本期淨利（淨損） | -115.0% | -89.5% | -73.6% | -83.9% | -113.3% | -78.0% | -27.2% | 40.4% | -20.2% | -23.5% | |
| 本期淨利（淨損） | -115.0% | -89.5% | -73.6% | -83.9% | -113.3% | -78.0% | -27.2% | 40.4% | -20.2% | -23.5% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | 1.3% | 1.8% | -1.3% | -3.2% | 1.3% | 1.6% | 1.1% | 3.9% | |
| 不重分類至損益之項目： | – | – | – | 5.1% | -1.3% | -3.2% | 1.3% | 1.6% | 1.1% | 3.9% | |
| 國外營運機構財務報表換算之兌換差額 | 0.0% | -3.7% | 0.1% | 1.3% | -3.1% | 3.9% | -4.2% | -0.8% | -0.5% | 2.1% | |
| 後續可能重分類至損益之項目： | – | – | – | 1.3% | -3.1% | 3.9% | -4.2% | -0.8% | -0.5% | 2.1% | |
| 其他綜合損益（淨額） | 5.6% | -1.8% | 5.3% | 6.4% | -4.4% | 0.7% | -2.9% | 0.7% | 0.6% | 6.0% | |
| 本期綜合損益總額 | -109.5% | -91.3% | -68.3% | -77.5% | -117.7% | -77.3% | -30.1% | 41.2% | -19.6% | -17.5% | |
| 母公司業主（淨利∕損） | -115.0% | -89.5% | -73.6% | -83.9% | -113.3% | -78.0% | -26.3% | 40.7% | -17.2% | -23.2% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | -0.9% | -0.3% | -3.0% | -0.3% | |
| 母公司業主（綜合損益） | -109.5% | -91.3% | -68.3% | -77.5% | -117.7% | -77.3% | -29.2% | 41.4% | -16.6% | -17.2% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | -0.9% | -0.3% | -3.0% | -0.3% | |
| 繼續營業單位淨利（淨損） | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | – | -0.0% | |
| 基本每股盈餘 | -0.8% | -0.6% | -1.7% | -2.0% | -1.8% | -1.1% | -1.5% | 1.8% | -0.7% | -1.0% | |
| 稀釋每股盈餘 | – | – | – | – | – | – | – | – | -0.7% | – | |
| 確定福利計畫之再衡量數 | 5.5% | 3.8% | 3.9% | 3.3% | 0.0% | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | 0.0% | -1.9% | 0.0% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。